Eli Lilly, Novo Nordisk and Sanofi CEOs to testify before Senate on lowering insulin prices
April 21, 2023 at 12:52 PM EDT
Eli Lilly, Novo Nordisk and Sanofi control 90% of the insulin market in the U.S, where a quarter of all health care spending is on people with diabetes.
